Department of Pharmacy, Faculty of Science, National University of Singapore, Block S4A, Level 3, 18 Science Drive 4, Singapore, 117543, Singapore.
Department of Electrical and Computer Engineering, Faculty of Engineering, National University of Singapore, Block E4, Level 5, 4 Engineering Drive 3, Singapore, 117583, Singapore.
J Med Syst. 2019 Feb 6;43(3):63. doi: 10.1007/s10916-019-1168-x.
Smartphone apps can potentially help in enhancing oral anticancer medication (OAM) adherence. Patient adoption and efficacy of such apps depends on inclusion of user-centred and evidence-based features. The objective of this study was to identify important design considerations from the perspectives of patients taking OAMs, caregivers and oncology pharmacists. The study employed a qualitative study design. Data were collected using in-depth interviews with patients (n = 15), caregivers (n = 3) and pharmacists (n = 16). Interviews were audio-recorded, transcribed verbatim and inductive thematic analysis approach was used in data analysis. Monitoring medication-related problems, medication information, replacement of or integration with current systems and accessibility of app content on devices other than smartphones were the key themes identified in the analysis. Flexible input methods for monitored data, glanceability of monitored reports/information, near real-time adherence enhancing and symptom management interventions and customisable reminder options were design considerations identified under the monitoring medication-related problems theme. Participants suggested the provision of focused and easily understandable medication information with a potential for personalisation. Integration of app-based adherence systems with patients' electronic medical records with added mechanisms for alerts in the dispensing system was also suggested as a key design requirement to improve quality of patient care and facilitate adoption by clinicians. Finally, smartphones were the most favoured platform with optional accessibility of app content on other devices. In conclusion, important design considerations were identified through a user-centred design approach. The findings will help developers and clinicians in the design of new app-based systems and evaluation of existing ones.
智能手机应用程序有可能有助于提高口服抗癌药物(OAM)的依从性。患者对这些应用程序的采用和疗效取决于纳入以用户为中心和基于证据的功能。本研究的目的是从服用 OAM 的患者、护理人员和肿瘤药剂师的角度确定重要的设计注意事项。该研究采用定性研究设计。通过对患者(n=15)、护理人员(n=3)和药剂师(n=16)进行深入访谈收集数据。访谈进行了录音,并逐字转录,采用归纳主题分析方法进行数据分析。分析确定了监测药物相关问题、药物信息、替代或整合当前系统以及在智能手机以外的设备上访问应用程序内容等关键主题。在监测药物相关问题主题下确定了一些设计注意事项,包括监测数据的灵活输入方法、监测报告/信息的易读性、接近实时的增强依从性和症状管理干预措施以及可定制的提醒选项。参与者建议提供重点突出且易于理解的药物信息,并具有个性化的潜力。还建议将基于应用程序的依从性系统与患者的电子病历集成,并在配药系统中增加警报机制,这是提高患者护理质量和促进临床医生采用的关键设计要求。最后,智能手机是最受欢迎的平台,其他设备也可以选择访问应用程序内容。总之,通过以用户为中心的设计方法确定了重要的设计注意事项。研究结果将有助于开发人员和临床医生设计新的基于应用程序的系统和评估现有的系统。